| Literature DB >> 31337049 |
Krystian Wochna1, Alicja Nowak2, Anna Huta-Osiecka2, Katarzyna Sobczak3, Zbigniew Kasprzak2, Piotr Leszczyński4.
Abstract
The purpose of this study was to analyze the influence of aqua fitness training in deep water on bone tissue. The study was performed with 18 postmenopausal women separated into two groups: training and control groups. Before and after the training program, the hip and spine areal bone mineral density were measured along with the biochemical parameters of serum concentration of osteocalcin (OC) and C-terminal telopeptide of type I collagen (CTX). The most significant effect was found in differences between the two groups of women in terms of femur strength index (p < 0.05) during the period of the training program. The study demonstrated that an aqua fitness training program caused favorable changes in femur strength index in postmenopausal women, and this kind of exercise could be a useful form of physical activity for postmenopausal women.Entities:
Keywords: aqua fitness; bone mass; bone metabolism; postmenopausal women
Mesh:
Substances:
Year: 2019 PMID: 31337049 PMCID: PMC6678096 DOI: 10.3390/ijerph16142505
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Somatic features before and after the intervention in the training and control groups.
| Parameters | Assessment at Baseline | Assessment at 6 Months | |
|---|---|---|---|
| Body mass (kg) | T | 71.16 (11.10); 71.50 (65.80–73.70) | 71.34 (11.90); 68.30 (64.70–74.30) |
| C | 77.06 (13.85); 78.70 (66.10–86.10) | 77.26 (13.95); 78.70 (65.10–87.00) | |
| BMI (kg/m2) | T | 27.49 (3.48); 28.28 (24.24–28.60) | 27.72 (3.92); 27.00 (25.10–29.00) |
| C | 28.54 (4.39); 28.08 (24.73–32.55) | 28.78 (4.51); 29.00 (25.10–32.50) | |
| Total fat (%) | T | 41.07 (5.97); 40.10 (39.30–45.60) | 40.46 (6.29); 39.60 (38.50–45.10) |
| C | 41.28 (6.68); 44.50 (35.80–47.50) | 41.29 (6.57); 44.20 (36.00–46.30) | |
| Lean body mass (kg) | T | 39.71 (4.42); 40.46 (37.71–41.36) | 40.18 (3.89); 40.60 (37.38–41.90) |
| C | 42.65 (4.14); 41.41 (40.45–45.61) | 42.82 (4.35); 41.34 (40.156–44.00) | |
| Total fat (kg) | T | 28.30 (7.98); 27.50 (24.39–30.74) | 28.10 (8.88); 26.96 (24.49–29.83) |
| C | 31.22 (10.13); 36.12 (22.32–37.68) | 31.31 (10.04); 36.70 (22.06–38.12) | |
| Android fat tissue (%) | T | 45.17 (8.14); 45.70 (42.70–51.80) | 43.83 (9.41); 44.00 (42.10–50.00) |
| C | 46.34 (8.16); 44.80 (39.70–54.20) | 45.90 (7.72); 45.70 (40.20–53.10) | |
| Gynoid fat tissue (%) | T | 48.09 (5.08); 50.10 (44.90–52.00) | 46.79 (4.96); 47.70 (43.40–50.50) |
| C | 45.96 (6.48); 47.30 (42.10–51.30) | 45.88 (5.66); 45.90 (43.70–50.20) |
Results are expressed as mean (SD); median (interquartile range).
Areal bone mineral density, femur strength index and bone turnover markers before and after the intervention in the training and control groups.
| Parameters | Assessment at Baseline | Assessment at 6 Month | |
|---|---|---|---|
| Total BMD (g/cm2) | T | 1.12 (0.13); 1.09 (1.05–1.21) | 1.11 (0.11); 1.09 (1.07–1.19) |
| C | 1.13 (0.08); 1.14 (1.11–1.16) | 1.13 (0.08); 1.14 (1.13–1.14) | |
| BMD L1–L4 (g/cm2) | T | 1.05 (0.21); 1.02 (0.91–1.21) | 1.04 (0.20); 1.00 (0.87–1.18) |
| C | 1.11 (0.09); 1.11 (1.08–1.19) | 1.11 (0.10); 1.13 (1.05–1.17) | |
| BMD total femur (g/cm2) | T | 0.95 (0.16); 0.93 (0.83–1.11) | 0.94 (0.16); 0.91 (0.83–1.12) |
| C | 0.94 (0.09); 0.95 (0.90–0.96) | 0.94 (0.10); 0.94 (0.89–0.96) | |
| BMD femoral neck (g/cm2) | T | 0.90 (0.16); 0.88 (0.76–1.08) | 0.90 (0.16); 0.88 (0.77–1.06) |
| C | 0.90 (0.09); 0.92 (0.85–0.98) | 0.90 (0.09); 0.93 (0.83–0.97) | |
| Femur strength index (N) | T | 1.31 (0.28); 1.30 (1.20–1.50) | 1.42 (0.34); 1.40 (1.20–1.70) * |
| C | 1.27 (0.18); 1.30 (1.20–1.40) | 1.19 (0.24); 1.10 (1.10–1.40) | |
| T–score L1–L4 | T | −1.06 (1.73); −1.30 (−2.20–0.20) | −1.19 (1.69); −1.50 (−2.6–0.00) |
| C | −0.57 (0.77); −0.60 (−0.90–0.10) | −0.60 (0.81); −0.50 (−1.10–−0.10) | |
| T–score total femur | T | −0.48 (1.28); −0.70 (−1.40–0.80) | −0.52 (1.28); −0.80 (−1.50–0.90) |
| C | −0.50 (0.70); −0.50 (−0.90–−0.40) | −0.52 (0.82); −0.50 (−0.90–−0.40) | |
| T–score femoral neck | T | −1.00 (1.18); −1.20 (−2.00–0.30) | −1.01 (1.16); −1.10 (−2.00–0.20) |
| C | −1.01 (0.65); −0.90 (−1.40–−0.40) | −1.00 (0.65); −0.70 (−1.50–−0.50) | |
| OC (ng/mL) | T | 1.47 (0.67); 1.39 (1.17–1.92) | 1.78 (1.00); 1.53 (1.20–2.37) |
| C | 1.70 (0.70); 1.84 (1.04–2.17) | 1.69 (0.80); 1.73 (0.94–2.30) | |
| CTX (ng/mL) | T | 0.36 (0.10); 0.30 (0.29–0.37) | 0.38 (0.11); 0.35 (0.32–0.42) |
| C | 0.53 (0.37); 0.44 (0.27–0.66) | 0.56 (0.22); 0.61 (0.34–0.73) |
Results are expressed as mean (SD); median (interquartile range). * indicates a significant difference (p < 0.05).
Figure 1The interaction with respect to the femur strength index at baseline and after six months of the training program between the training and control groups.